Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis

NCT07113574 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

12

Enrollment

NETWORK

Sponsor class

Conditions

Peritoneal Dialysis Associated Peritonitis
Peritoneal Dialysis (PD)
Peritoneal Dialysis
Peritoneal Dialysis, Continuous Ambulatory
Meropenem
Aztreonam
Antibacterial Agents
Intraperitoneal Antibiotics
Kidney Failure, Chronic
Anti-Bacterial Agents
Drug Therapy

Interventions

DRUG: Meropenem 1000 mg
DRUG: Aztreonam 2000 mg
OTHER: automated peritoneal dialysis with following long time dwell
DIAGNOSTIC_TEST: Sampling

Sponsor

Karl Landsteiner Insitute for Nephrology and Haemato-Oncology

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]